Selecting DHA + ARA Combined Emulsions: 3 Key Indicators – Active Content, Fatty Acid Ratio And Antioxidant System

Aug 05, 2026

A growing number of DHA+ARA combined emulsions (including liquid emulsions, emulsified drops, fortified liquids for formula milk) market themselves with slogans such as "dual nutrient supplementation" and "brain & eye nutrition partners". Many parents assume products containing both DHA and ARA are scientifically superior to DHA-only supplements. Yet disappointment often follows purchase: labelled DHA content of 100 mg may only deliver 70 mg in reality; products claiming a 1:1 ratio can deviate drastically from breastmilk composition; some develop rancid odour after two months on a windowsill, which infants refuse to consume.

 

Unlike solid capsules, combined emulsions blend DHA algal oil, ARA oil, water and emulsifiers. The expanded oil-water interface creates greater oxygen exposure, making emulsions far more susceptible to oxidation than pure oil formulations. When choosing such products, ignore fancy marketing concepts and focus strictly on three measurable criteria: active nutrient content, fatty acid ratio and antioxidant protection system.

 

1. Active Nutrient Content: Verify Measured Net DHA & ARA; Do Not Rely on Total Emulsion/Oil Weight

 

This pitfall mirrors the common issue with algal oil capsules, yet emulsions offer even more room for misleading labelling. A package labelled "30 mL combined emulsion containing 5,000 mg DHA algal oil" sounds impressive. However, algal oil only contains 35%–50% DHA, with the remainder consisting of other fatty acids. After accounting for ARA oil, emulsifiers and water, actual DHA concentration may only reach 20–30 mg per 1 mL.

 

Correct evaluation method:

  • Locate the nutrition facts panel or instructions stating DHA ___ mg, ARA ___ mg per 1 mL / per serving. Disregard figures referencing "total algal oil weight" or "total emulsion volume".
  • Compare net content against recommendations from the Chinese Nutrition Society: Adequate Intake (AI) of DHA = 100 mg/day for infants aged 0–6 months; ARA intake targets approximate breastmilk levels; pregnant and lactating women require 200 mg DHA daily.
  • Reference national standards for infant food: GB 10765-2021 specifies DHA levels of 3.6–9.6 mg/100 kJ for Stage 1 infant formula, with a maximum ARA limit of 19.1 mg/100 kJ. Where DHA is added, ARA content must be equal or higher. Peer-reviewed breastmilk data establishes an optimal design range: DHA 5.3–7.5 mg/100 kJ, ARA 8.0–10.4 mg/100 kJ.

 

Example: An emulsion providing 25 mg DHA and 40 mg ARA per mL delivers 100 mg DHA and 160 mg ARA with a daily 4 mL dosage, aligning with breastmilk reference levels and considered reasonable. Products supplying merely 10 mg DHA and 10 mg ARA per mL offer minimal nutritional contribution.

 

How to avoid deception: Many e-commerce pages prominently advertise "high-purity algal oil", while fine print notes "DHA purity 35%". Marketers calculate total DHA by multiplying emulsion volume by algal oil mass, falsely inflating values. Calculation example: 3,000 mg total algal oil ÷ 30 mL = 100 mg algal oil/mL. Multiply by 35% purity = 35 mg actual DHA/mL. Disregard products with inconsistent labelling.

 

2. Fatty Acid Ratio: Maintain DHA:ARA between 1:1 and 1:2; Minimise EPA for Infant Formulations

 

Breastmilk provides the gold standard reference. Mature breastmilk globally contains approximately 0.32%–0.40% DHA and 0.47% ARA of total fatty acids, creating a natural DHA:ARA ratio of 1:1.2 ~ 1:1.5. WHO guidance recommends an ARA:DHA ratio close to 2:1 (equivalent to DHA:ARA ≈1:2).

 

Selection guidelines:

  • Infants aged 0–3 years, pregnant & lactating women: Prioritise DHA:ARA ratio from 1:1 to 1:2. Excess DHA (e.g. 2:1) restricts ARA availability, impairing nerve cell membrane integrity and synthesis of inflammatory signalling precursors. An overly high ARA proportion (e.g. 1:3) is unnecessary, as breastmilk does not reach such levels.
  • Regulatory baseline under GB 10765-2021: If DHA is added to infant formula, ARA must be included at equal or higher concentrations. Reputable manufacturers producing infant emulsions follow this requirement.
  • EPA control: As covered previously, infant-grade products require EPA <0.3% of total fatty acids. Emulsions blended with EPA-containing algal oil or fish oil risk competitive inhibition of Δ6-desaturase when EPA levels rise. Review test reports: for infant use, EPA mass should ideally be less than 1/10 of DHA mass.
  • Adult formulations (35+ years): The 1:1~1:2 ratio is not mandatory; standalone DHA supplementation is acceptable. Combined DHA+ARA adult products often adopt DHA:ARA ≈2:1 or 3:1. Adults naturally consume ARA via meat and eggs; excessive supplementary ARA increases omega-6 burden. Critical reminder: Never administer adult formulations to infants.
  • Practical screening rule: Skip products only labelled with vague phrasing like "scientific balance" without clear DHA:ARA figures. Trust transparent brands providing batch test reports specifying ratios such as "25 mg DHA : 38 mg ARA (~1:1.5), EPA <0.1 mg".

 

3. Antioxidant System: Emulsions Are More Vulnerable to Oxidation – Evaluate Internal Antioxidants + External Packaging

 

DHA contains six double bonds and ARA four; both highly unsaturated fatty acids oxidise rapidly upon oxygen exposure. Emulsification breaks oil droplets into nano-sized particles via emulsifiers, expanding surface area exposed to oxygen dozens of times compared with bulk oil. Research confirms fortified infant formula containing high DHA/ARA develops significant nutrient loss and elevated TBARS (oxidation by-products) after six months storage at 37°C without sufficient antioxidants such as vitamin E and vitamin C derivatives.

 

Four aspects to assess the antioxidant system:

 

(1) Internal approved antioxidants

Safe options suitable for infants:

  • Natural Vitamin E (mixed tocopherols): The most widely used stabiliser. Studies confirm optimal DHA stability at 8 mg/100 g in formula; a VE:ascorbyl palmitate (AP) ratio of 3:2 outperforms 3:1.
  • Ascorbyl palmitate (lipid-soluble vitamin C derivative): Works synergistically with vitamin E.
  • Microencapsulation wall materials: DHA/ARA oil droplets encapsulated with maltodextrin, whey protein, casein or cyclodextrin create a physical oxygen barrier. Studies show microencapsulated dry addition achieves substantially slower oxidation than direct liquid oil blending.
  • Avoid: TBHQ (tert-butylhydroquinone), commonly used in adult fish oil, is restricted for infant food. Penalise any infant emulsion listing TBHQ in ingredients.

 

(2) Pro-oxidant factors within emulsion matrix

Free iron or copper ions (sometimes introduced when blended with mineral drops) and high concentrations of fructose/glucose accelerate oxidation. Quality formulations use chelators such as citric acid to bind metal ions. Key indicators from batch test reports: Peroxide value (POV) ≤1.5 meq/kg indicates freshness; discard products exceeding 5 meq/kg for infants. Anisidine value should also comply with limits.

 

(3) Oxygen & light barrier packaging

  • Amber glass / aluminium light-proof bottles > transparent plastic bottles
  • Nitrogen-flushed filling (audible "pop" when opening) > standard filling
  • Single-serve sachets > large multi-dose bottles opened repeatedly for one month
  • Research demonstrates that under identical microencapsulation conditions, POV in light-protected samples is 7.5 meq/kg lower than light-exposed samples after 12 days; vacuum packaging achieves POV 2.6 meq/kg lower than aerobic packaging.

 

(4) Shelf life and post-opening usage window

Oxidation accelerates drastically once emulsions are opened. Reliable brands clearly state "use within 30 days after opening" and "refrigerate". Absence of such instructions indicates insufficient confidence in formulation stability. Avoid products within three months of expiry, even at discounted prices – unsaturated oils accumulate oxidation metabolites nearing shelf-life end.

 

Example of a fully qualified antioxidant configuration: Ingredients: DHA algal oil, ARA oil, vitamin E, ascorbyl palmitate, citric acid, maltodextrin (microcapsule wall material). Packaging: Amber glass dropper bottle with nitrogen sealing. Test report: POV = 0.8 meq/kg, acceptable anisidine value; labelled "refrigerate and consume within 30 days after opening".

 

Quick Self-Check Checklist for DHA+ARA Combined Emulsions

 

Work through the following criteria sequentially:

  • Active content: Clear DHA mg and ARA mg stated per 1 mL / per serving. Infant formulations should deliver ~25–30 mg DHA per mL (3–4 mL daily to reach 100 mg DHA). Reject products only listing total algal oil mass.
  • Fatty acid ratio: DHA:ARA within 1:1 ~ 1:2 for infants, pregnant and lactating users; EPA maintained at minimal levels (<0.3% total fatty acids). Adult formulations follow separate standards and must not be given to infants.
  • Antioxidant protection: Internal system with vitamin E + ascorbyl palmitate + microencapsulation; external light-blocking packaging + nitrogen filling; clear post-opening guidance; batch report confirming POV <1.5 meq/kg.
  • Products meeting all three criteria are safe to mix into infant milk. No matter how attractive promotional visuals appear, reject items failing any requirement.

Final note: The main advantage of DHA+ARA emulsions is a fixed, ready-to-use ratio without manual calculation from separate supplements. However, emulsion formats are inherently less stable than capsules. Avoid storage on kitchen windowsills after purchase; refrigerate immediately after opening and consume within the specified timeframe. Careful product selection is only half the process. Proper storage prevents oxidation, ensuring intact nutrients are delivered to children.

 

Primary References

  1. GB 10765-2021 National Food Safety Standard: Infant Formula (DHA 3.6–9.6 mg/100 kJ; ARA ≥ DHA if DHA is incorporated)
  2. Zhao Liangjun et al. Research on Scientific Design Range of DHA and ARA in Infant Formula, China Dairy Industry, 2025 (Optimal range: DHA 5.3–7.5 mg/100 kJ, ARA 8.0–10.4 mg/100 kJ)
  3. Chinese Nutrition Society, Chinese Dietary Reference Intakes (2023 Edition): DHA AI 100 mg/day for infants 0–6 months; DHA:ARA intake ratio 1.4:1 ~ 2:1 supports brain and visual development
  4. Research on oxidative stability of fats in infant formula: Optimal VE dosage 8 mg/100 g; VE:AP ratio 3:2 superior to 3:1; microcapsule dry addition slows oxidation vs wet blending
  5. Stabilisation study on microencapsulated algal DHA: Antioxidant combination VE + ascorbyl palmitate + TBHQ; maltodextrin/casein/cyclodextrin spray-dried wall materials
  6. Impact of fermented whey protein antioxidant peptides on microencapsulated DHA: POV 7.5 meq/kg lower in light-shielded samples after 12 days; vacuum packaging outperforms aerobic storage (Food Research and Development)
  7. WHO guidance: Infant ARA:DHA ≈2:1; breastmilk DHA:ARA ≈1:1.2–1:1.5 (summarised by Formula Milk Think Tank)
You Might Also Like